The cardiovascular responses to the addition of nitrous oxide to fluroxene in man.
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000328:Adult; D000777:Anesthetics / Q000494:pharmacology*; D002245:Carbon Dioxide / Q000378:metabolism; D002302:Cardiac Output / Q000187:drug effects; D004357:Drug Synergism; D004987:Ethers / Q000494:pharmacology*; D005461:Fluorine / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008297:Male; D009609:Nitrous Oxide / Q000494:pharmacology*; D010101:Oxygen Consumption; D010991:Plethysmography; D014655:Vascular Resistance / Q000187:drug effects
D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D000777:Anesthetics; D004987:Ethers; D002245:Carbon Dioxide; D005461:Fluorine; D009609:Nitrous Oxide